Clinical Trials
132
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (105 trials with phase data)• Click on a phase to view related trials
Feasibility of a Behavioural Activation Protocol to Support People With Parkinson's Enhanced by VR
- Conditions
- Parkinson Disease
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Queen's University, Belfast
- Target Recruit Count
- 13
- Registration Number
- NCT07038603
- Locations
- 🇬🇧
Marie Curie, Belfast, United Kingdom
Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal
- Conditions
- Rhegmatogenous Retinal Detachment
- First Posted Date
- 2025-05-30
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- Queen's University, Belfast
- Target Recruit Count
- 276
- Registration Number
- NCT06997874
- Locations
- 🇬🇧
Buckinghamshire Healthcare NHS Trust, Aylesbury, United Kingdom
🇬🇧Belfast Health and Social Care Trust, Belfast, United Kingdom
🇬🇧Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom
Determining the Effect of Food Ordering on Blood Glucose In Gestational Diabetes Mellitus (DEFI-GDM)
- Conditions
- Gestational Diabetes Mellitus (GDM)
- First Posted Date
- 2025-03-26
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Queen's University, Belfast
- Target Recruit Count
- 35
- Registration Number
- NCT06896799
- Locations
- 🇬🇧
Centre for Public Health, Institute of Clinical Sciences A, Belfast, United Kingdom
Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health
- Conditions
- Cardiometabolic Risk Factors
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Queen's University, Belfast
- Target Recruit Count
- 330
- Registration Number
- NCT06749327
- Locations
- 🇮🇪
University College Dublin, Dublin, Ireland
🇬🇧Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
Virtual Reality and Post Traumatic Stress
- Conditions
- PTSD - Post Traumatic Stress Disorder
- First Posted Date
- 2024-11-12
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Queen's University, Belfast
- Target Recruit Count
- 15
- Registration Number
- NCT06684977
- Locations
- 🇬🇧
South Eastern Health and Social Care Trust (Regional Trauma Network), Belfast, Dundonald, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 21
- Next
News
Iridex Enrolls First Patient in DAME Trial Testing MicroPulse Laser as Adjunct to Anti-VEGF Therapy for Severe Diabetic Macular Edema
Iridex Corporation has enrolled the first patient in the independent DAME trial, which will evaluate whether adding subthreshold MicroPulse laser treatment to anti-VEGF therapy can reduce injection burden for severe diabetic macular edema patients.
Weight Loss Injections Show Promising Anti-Cancer Effects Beyond Weight Reduction
Research presented at the European Congress on Obesity suggests weight loss injections may reduce obesity-related cancer risk by nearly 50%, potentially through anti-inflammatory mechanisms beyond simple weight reduction.
Belfast-Based Amply Discovery Secures $1.75M to Accelerate AI-Driven Drug Development for Cancer and Antimicrobial Resistance
Belfast biotech startup Amply Discovery has raised $1.75 million in seed funding to advance its AI-powered drug discovery platform targeting aggressive cancers and antimicrobial resistance.
Semaglutide Drugs Ozempic and Wegovy Linked to Increased Risk of Blinding Eye Condition in New Study
A Harvard-led study found patients prescribed semaglutide (Ozempic/Wegovy) were 4-7 times more likely to develop NAION, a rare eye condition causing permanent vision loss.